S1803
|
SWOG
|
Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC STUDY)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1806
|
SWOG
|
Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1815
|
SWOG
|
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1820
|
SWOG
|
A Randomized Trial of the Altering Intake, Managing Symptoms Intervention for Bowel Dysfunction in Rectal Cancer Survivors Compared to a Healthy Living Education Control: A Feasibility and Preliminary Efficacy Study (AIMS-RC)
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
S1823
|
SWOG
|
A Prospective Observational Cohort Study To Assess miRNA 371 For Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
S1826
|
SWOG
|
A Phase III, Randomized Study of Nivolumab (Opdivo) plus AVD or Brentuximab Vedotin (Adcetris) plus AVD in Patient (Age >/= 12 Year) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1827
|
SWOG
|
MRI Brain Surveillance Alone versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1900A
|
SWOG
|
A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LungMAP Sub-Study)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1900B
|
SWOG
|
A Phase II Study of LOXO-292 in Patients with RET Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LungMAP Sub-Study)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1900C
|
SWOG
|
A Phase II Study of Talazoparib plus Avelumab in Patients with Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer Bearing Pathogenic STK11 Genomic Alterations (LungMAP Sub-Study)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|